Re:When the Patient Is a Gold Mine: The Trouble with Rare-Di...
by rayiner on Thursday May 25, 2017 @07:54AM
(#14416739)
There is no economic system in which the skilled educated labor necessary to create these drugs can be compensated by what money you can get from a relatively small number of poor people with s rare disease. You cut $300,000 per year for treatment to $30,000 per year, and this company is operating at huge losses. And it's still not affordable to even normal people.
[ Parent
| on HN ]
There are no comments on this comment yet.